Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 116949
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116949
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116949
Table 3 Effects of upper gastrointestinal endoscopic screening on cessation of cigarette smoking, alcohol drinking and unhealthy dietary habit, stratified by sex, baseline age and baseline gastrointestinal symptoms score
| Stratified variable | Cessation of cigarette smoking (n = 5600)1 | Cessation of alcohol drinking (n = 4949)2 | Reduction of unhealthy dietary habit | ||||||
| Outcome events/total (%) | Adjusted OR (95%CI) | P value | Outcome events/total (%) | Adjusted OR (95%CI) | P value | Outcome events/total (%) | Adjusted OR (95%CI) | P value | |
| Sex | |||||||||
| Female | 48/94 (51.06) | 1.50 (0.58-3.85) | 0.399 | 42/63 (66.67) | 1.56 (0.37-6.53) | 0.546 | 5550/13255 (41.87) | 1.12 (1.04-1.20) | 0.002 |
| Male | 1408/5506 (25.57) | 1.19 (1.05-1.35) | 0.007 | 2032/4886 (41.59) | 1.32 (1.17-1.49) | < 0.001 | 4379/11374 (38.50) | 1.02 (0.94-1.10) | 0.617 |
| Interaction4 | 0.557 | 0.181 | 0.033 | ||||||
| Baseline age | |||||||||
| < 60 | 700/3241 (21.60) | 1.16 (0.98-1.38) | 0.089 | 1108/3026 (36.62) | 1.16 (0.99-1.35) | 0.061 | 5752/14515 (39.63) | 1.03 (0.96-1.10) | 0.451 |
| ≥ 60 | 756/2359 (32.05) | 1.23 (1.03-1.47) | 0.024 | 966/1923 (50.23) | 1.66 (1.38-2) | < 0.001 | 4177/10114 (41.30) | 1.14 (1.05-1.24) | 0.001 |
| Interaction4 | 0.589 | 0.004 | 0.130 | ||||||
| Baseline gastrointestinal symptoms score | |||||||||
| 0 | 795/3092 (25.71) | 1.16 (0.98-1.37) | 0.087 | 997/2586 (38.55) | 1.41 (1.20-1.67) | < 0.001 | 5322/13578 (39.20) | 1.08 (1.01-1.16) | 0.029 |
| ≥ 1 | 661/2508 (26.36) | 1.25 (1.04-1.51) | 0.018 | 1077/2363 (45.58) | 1.26 (1.07-1.49) | 0.007 | 4607/11051 (41.69) | 1.06 (0.98-1.14) | 0.158 |
| Interaction4 | 0.488 | 0.436 | 0.662 | ||||||
- Citation: Cheng XW, Liu Z, Guo CH, Li FL, Pan YQ, Liu Y, Liu FF, Chen HY, Yang WL, Tian HR, Shi C, He ZH, Liu MF, Ke Y. Upper gastrointestinal endoscopic screening serves as a primary prevention approach by reducing modifiable risk factors. World J Gastrointest Oncol 2026; 18(4): 116949
- URL: https://www.wjgnet.com/1948-5204/full/v18/i4/116949.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i4.116949